Skip to main content
Premium Trial:

Request an Annual Quote

Travis Lacey, Dale Gordon, Gary Altman, Steven Ness

Human Longevity has hired several new senior staff. Travis Lacey was named chief corporate development officer; Dale Gordon was named chief commercial officer; Gary Altman was named chief operating officer; and Steven Ness was named chief services lead. Lacey comes from GE Healthcare where he was the managing director, leading the divestiture practice and portfolio optimization. Before that he was with investment banks Jefferies and R.W. Baird. Gordon was most recently GM of account management at GE Healthcare. Prior to that, he was with EMD Millipore, now Millipore Sigma and part of Merck KGaA. Altman has more than 25 years of experience leading startups and has served as CEO, COO, VP, and GM at various firms. Ness most recently was director of client services at GE Healthcare's Clarient Diagnostics business. Previously, he held medical affairs and marketing positions at Quidel. 

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.